Publications by Asta Juzeniene

111 publications found

  1. Kvassheim M, Tornes AJK, Juzeniene A, Stokke C, Revheim MR (2023)
    Imaging of 212Pb in mice with a clinical SPECT/CT
    EJNMMI Phys, 10 (1), 47
    DOI 10.1186/s40658-023-00571-6, PubMed 37603123
  2. Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
    Nat Commun, 14 (1), 3375
    DOI 10.1038/s41467-023-39097-x, PubMed 37291203
  3. Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
    Editorial: Targeted alpha particle therapy in oncology
    Front Med (Lausanne), 10, 1165747
    DOI 10.3389/fmed.2023.1165747, PubMed 36960341
  4. Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
    Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
    Front Med (Lausanne), 9, 1051825
    DOI 10.3389/fmed.2022.1051825, PubMed 36733936
  5. Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
    Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
    Front Med (Lausanne), 9, 1058863
    DOI 10.3389/fmed.2022.1058863, PubMed 36507500
  6. Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE (2023)
    Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study
    Int J Epidemiol, 52 (3), 887-898
    DOI 10.1093/ije/dyac223, PubMed 36413027
  7. Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
    Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001
    Cancers (Basel), 14 (11)
    DOI 10.3390/cancers14112784, PubMed 35681766
  8. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand 212Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
  9. Li RG, Lindland K, Tonstad SK, Bønsdorff TB, Juzeniene A, Westrøm S, Larsen RH (2021)
    Improved Formulation of 224Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP
    Pharmaceutics, 13 (5)
    DOI 10.3390/pharmaceutics13050634, PubMed 33946852
  10. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
    Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Cancers (Basel), 13 (4)
    DOI 10.3390/cancers13040779, PubMed 33668474
  11. Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Ghiasvand R, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
    Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
    Clin Epidemiol, 12, 1389-1401
    DOI 10.2147/CLEP.S269446, PubMed 33376408
  12. Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
    Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
    Curr Radiopharm, 14 (2), 145-153
    DOI 10.2174/1874471013666201201102056, PubMed 33261548
  13. Köksal H, Dillard P, Juzeniene A, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2020)
    Combinatorial CAR design improves target restriction
    J Biol Chem, 296, 100116
    DOI 10.1074/jbc.RA120.016234, PubMed 33234592
  14. Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
    Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples
    Appl Radiat Isot, 166, 109362
    DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
  15. Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
    In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
    Curr Radiopharm, 13 (2), 130-141
    DOI 10.2174/1874471013666200511000532, PubMed 32389119
  16. Grigalavicius M, Mastrangelopoulou M, Arous D, Juzeniene A, Ménard M, Skarpen E, Berg K, Theodossiou TA (2020)
    Photodynamic Efficacy of Cercosporin in 3D Tumor Cell Cultures
    Photochem Photobiol, 96 (3), 699-707
    DOI 10.1111/php.13257, PubMed 32125700
  17. Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
    Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
    Clin Epidemiol, 12, 193-202
    DOI 10.2147/CLEP.S241249, PubMed 32110111
  18. Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
    Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer
    J Labelled Comp Radiopharm, 63 (3), 129-143
    DOI 10.1002/jlcr.3825, PubMed 31919866
  19. Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE (2019)
    Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study
    BMJ Open, 9 (2), e025246
    DOI 10.1136/bmjopen-2018-025246, PubMed 30787091
  20. Juzeniene A, Bernoulli J, Suominen M, Halleen J, Larsen RH (2018)
    Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model
    Anticancer Res, 38 (4), 1947-1955
    DOI 10.21873/anticanres.12432, PubMed 29599310
  21. Pudroma X, Duoji G, Grigalavicius M, Jie D, Juzeniene A (2017)
    Molecular Mechanisms of UVA-Induced Melanoma
    J Environ Pathol Toxicol Oncol, 36 (3), 217-228
    DOI 10.1615/JEnvironPatholToxicolOncol.2017020213, PubMed 29283335
  22. Gaware VS, Håkerud M, Juzeniene A, Høgset A, Berg K, Másson M (2017)
    Endosome Targeting meso-Tetraphenylchlorin-Chitosan Nanoconjugates for Photochemical Internalization
    Biomacromolecules, 18 (4), 1108-1126
    DOI 10.1021/acs.biomac.6b01670, PubMed 28245649
  23. Grigalavicius M, Juraleviciute M, Kwitniewski M, Juzeniene A (2016)
    The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells
    Photodiagnosis Photodyn Ther, 17, 29-34
    DOI 10.1016/j.pdpdt.2016.10.008, PubMed 27777143
  24. Juzeniene A, Grigalavicius M, Juraleviciute M, Grant WB (2016)
    Phototherapy and vitamin D
    Clin Dermatol, 34 (5), 548-55
    DOI 10.1016/j.clindermatol.2016.05.004, PubMed 27638432
  25. Grant WB, Karras SN, Bischoff-Ferrari HA, Annweiler C, Boucher BJ, Juzeniene A, Garland CF, Holick MF (2016)
    Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?
    Dermatoendocrinol, 8 (1), e1187349
    DOI 10.1080/19381980.2016.1187349, PubMed 27489574
  26. Grigalavicius M, Iani V, Juzeniene A (2016)
    Layer Thickness of SPF 30 Sunscreen and Formation of Pre-vitamin D
    Anticancer Res, 36 (3), 1409-15
    PubMed 26977044
  27. Juzeniene A, Grigalavicius M, Ma LW, Juraleviciute M (2016)
    Folic acid and its photoproducts, 6-formylpterin and pterin-6-carboxylic acid, as generators of reactive oxygen species in skin cells during UVA exposure
    J Photochem Photobiol B, 155, 116-21
    DOI 10.1016/j.jphotobiol.2016.01.001, PubMed 26780587
  28. Grigalavicius M, Moan J, Dahlback A, Juzeniene A (2015)
    Daily, seasonal, and latitudinal variations in solar ultraviolet A and B radiation in relation to vitamin D production and risk for skin cancer
    Int J Dermatol, 55 (1), e23-8
    DOI 10.1111/ijd.13065, PubMed 26547141
  29. Coelho SC, Pereira MC, Juzeniene A, Juzenas P, Coelho MAN (2015)
    Supramolecular nanoscale assemblies for cancer diagnosis and therapy
    J Control Release, 213, 152-167
    DOI 10.1016/j.jconrel.2015.06.034, PubMed 26160308
  30. Grigalavicius M, Moan J, Dahlback A, Juzeniene A (2015)
    Vitamin D and ultraviolet phototherapy in Caucasians
    J Photochem Photobiol B, 147, 69-74
    DOI 10.1016/j.jphotobiol.2015.03.009, PubMed 25846579
  31. Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
    Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
    Scand J Public Health, 43 (3), 324-30
    DOI 10.1177/1403494815572206, PubMed 25740614
  32. Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
    Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
    Anticancer Res, 35 (2), 1171-80
    PubMed 25667508
  33. Moan J, Grigalavicius M, Baturaite Z, Dahlback A, Juzeniene A (2014)
    The relationship between UV exposure and incidence of skin cancer
    Photodermatol Photoimmunol Photomed, 31 (1), 26-35
    DOI 10.1111/phpp.12139, PubMed 25213656
  34. Bugaj A, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2006)
    The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac(®)CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A fluorescence and extraction study
    Photodiagnosis Photodyn Ther, 3 (1), 27-33
    DOI 10.1016/S1572-1000(05)00109-2, PubMed 25049025
  35. Kaliszewski M, Juzeniene A, Juzenas P, Kwasny M, Kaminski J, Dabrowski Z, Golinski J, Moan J (2005)
    Formation of protoporphyrin IX from carboxylic- and amino-derivatives of 5-aminolevulinic acid
    Photodiagnosis Photodyn Ther, 2 (2), 129-34
    DOI 10.1016/S1572-1000(05)00012-8, PubMed 25048672
  36. Mikolajewska P, Juzeniene A, Moan J (2007)
    The effect of lidocaine on PpIX photobleaching and outcome of ALA-PDT in vitro
    Photodiagnosis Photodyn Ther, 4 (4), 249-53
    DOI 10.1016/j.pdpdt.2007.10.002, PubMed 25047561
  37. Bugaj A, Kwitniewski M, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2007)
    Photodynamic therapy with di-l-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice
    Photodiagnosis Photodyn Ther, 4 (4), 237-41
    DOI 10.1016/j.pdpdt.2007.08.001, PubMed 25047558
  38. Juzeniene A, Moan J (2006)
    The history of PDT in Norway Part II. Recent advances in general PDT and ALA-PDT
    Photodiagnosis Photodyn Ther, 4 (2), 80-7
    DOI 10.1016/j.pdpdt.2006.11.001, PubMed 25047338
  39. Juzeniene A, Moan J (2006)
    The history of PDT in Norway Part one: Identification of basic mechanisms of general PDT
    Photodiagnosis Photodyn Ther, 4 (1), 3-11
    DOI 10.1016/j.pdpdt.2006.11.002, PubMed 25047184
  40. Juzeniene A, Grigalavicius M, Baturaite Z, Moan J (2014)
    Minimal and maximal incidence rates of skin cancer in Caucasians estimated by use of sigmoidal UV dose-incidence curves
    Int J Hyg Environ Health, 217 (8), 839-44
    DOI 10.1016/j.ijheh.2014.06.002, PubMed 25023193
  41. Moan J, Grigalavicius M, Baturaite Z, Juzeniene A, Dahlback A (2013)
    North-South gradients of melanomas and non-melanomas: A role of vitamin D?
    Dermatoendocrinol, 5 (1), 186-91
    DOI 10.4161/derm.23791, PubMed 24494053
  42. Grigalavicius M, Juzeniene A, Baturaite Z, Dahlback A, Moan J (2013)
    Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma
    Dermatoendocrinol, 5 (1), 150-8
    DOI 10.4161/derm.22941, PubMed 24494048
  43. Juzeniene A, Iani V, Moan J (2013)
    Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid
    Photodiagnosis Photodyn Ther, 10 (4), 538-45
    DOI 10.1016/j.pdpdt.2013.05.008, PubMed 24284108
  44. Moan JE, Baturaite Z, Grigalavicius M, Juzeniene A (2013)
    Sunbed use and cutaneous melanoma in Norway
    Scand J Public Health, 41 (8), 812-7
    DOI 10.1177/1403494813496601, PubMed 23907734
  45. Juzeniene A, Thu Tam TT, Iani V, Moan J (2013)
    The action spectrum for folic acid photodegradation in aqueous solutions
    J Photochem Photobiol B, 126, 11-6
    DOI 10.1016/j.jphotobiol.2013.05.011, PubMed 23892004
  46. Orlova T, Moan J, Lagunova Z, Aksnes L, Terenetskaya I, Juzeniene A (2013)
    Increase in serum 25-hydroxyvitamin-D3 in humans after sunbed exposures compared to previtamin D3 synthesis in vitro
    J Photochem Photobiol B, 122, 32-6
    DOI 10.1016/j.jphotobiol.2013.03.006, PubMed 23591142
  47. Juzeniene A, Nizauskaite Z (2013)
    Photodegradation of cobalamins in aqueous solutions and in human blood
    J Photochem Photobiol B, 122, 7-14
    DOI 10.1016/j.jphotobiol.2013.03.001, PubMed 23558034
  48. Moan J, Baturaite Z, Grigalavicius M, Juzeniene A (2013)
    Cutaneous malignant melanoma incidence rates in Norway
    Scand J Public Health, 41 (4), 336-9
    DOI 10.1177/1403494813479216, PubMed 23439631
  49. Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
    Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
    Melanoma Res, 22 (6), 460-5
    DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822
  50. Juzeniene A, Moan J (2012)
    Beneficial effects of UV radiation other than via vitamin D production
    Dermatoendocrinol, 4 (2), 109-17
    DOI 10.4161/derm.20013, PubMed 22928066
  51. Uzdensky A, Kristiansen B, Moan J, Juzeniene A (2012)
    Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment: antibody microarray study
    Biochim Biophys Acta, 1820 (7), 795-803
    DOI 10.1016/j.bbagen.2012.03.008, PubMed 22484521
  52. Juzeniene A, Grant WB, Moan JE (2012)
    Reply to "Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials"
    Scand J Infect Dis, 44 (9), 712-3
    DOI 10.3109/00365548.2012.658580, PubMed 22385298
  53. Moan J, Nielsen KP, Juzeniene A (2011)
    Immediate pigment darkening: its evolutionary roles may include protection against folate photosensitization
    FASEB J, 26 (3), 971-5
    DOI 10.1096/fj.11-195859, PubMed 22159146
  54. Pudroma X, Juzeniene A, Ma LW, Iani V, Moan J (2011)
    Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes
    J Environ Pathol Toxicol Oncol, 30 (3), 235-40
    DOI 10.1615/jenvironpatholtoxicoloncol.v30.i3.60, PubMed 22126616
  55. Mikolajewska P, Rømoen OT, Martinsen OG, Iani V, Moan J, Grimnes S, Juzeniene A (2011)
    Bioimpedance for pain monitoring during cutaneous photodynamic therapy: Preliminary study
    Photodiagnosis Photodyn Ther, 8 (4), 307-13
    DOI 10.1016/j.pdpdt.2011.06.001, PubMed 22122917
  56. Moan J, Baturaite Z, Juzeniene A, Porojnicu AC (2011)
    Vitamin D, sun, sunbeds and health
    Public Health Nutr, 15 (4), 711-5
    DOI 10.1017/S1368980011002801, PubMed 22017922
  57. Micu E, Juzeniene A, Moan J (2011)
    Comparison of the time and latitude trends of melanoma incidence in anorectal region and perianal skin with those of cutaneous malignant melanoma in Norway
    J Eur Acad Dermatol Venereol, 25 (12), 1444-9
    DOI 10.1111/j.1468-3083.2011.04023.x, PubMed 21995584
  58. Moan J, Baturaite Z, Porojnicu AC, Dahlback A, Juzeniene A (2011)
    UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden
    Photochem Photobiol Sci, 11 (1), 191-8
    DOI 10.1039/c1pp05215b, PubMed 21986949
  59. Juzeniene A, Micu E, Porojnicu AC, Moan J (2011)
    Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway
    J Eur Acad Dermatol Venereol, 26 (7), 821-7
    DOI 10.1111/j.1468-3083.2011.04162.x, PubMed 21707773
  60. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011)
    Photodynamic therapy of cancer: an update
    CA Cancer J Clin, 61 (4), 250-81
    DOI 10.3322/caac.20114, PubMed 21617154
  61. Moan J, Dahlback A, Ma L, Juzeniene A (2009)
    Influenza, solar radiation and vitamin D
    Dermatoendocrinol, 1 (6), 307-9
    DOI 10.4161/derm.1.6.11357, PubMed 21572876
  62. Moan J, Cicarma E, Setlow R, Porojnicu AC, Grant WB, Juzeniene A (2010)
    Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation
    Dermatoendocrinol, 2 (1), 3-8
    DOI 10.4161/derm.2.1.11745, PubMed 21547141
  63. Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
    Seasonal variations of cancer incidence and prognosis
    Dermatoendocrinol, 2 (2), 55-7
    DOI 10.4161/derm.2.2.12664, PubMed 21547098
  64. Juzeniene A, Juzenas P, Iani V, Moan J (2010)
    Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate
    Photodiagnosis Photodyn Ther, 7 (4), 239-45
    DOI 10.1016/j.pdpdt.2010.07.001, PubMed 21112546
  65. Juzeniene A, Ma LW, Kwitniewski M, Polev GA, Lagunova Z, Dahlback A, Moan J (2010)
    The seasonality of pandemic and non-pandemic influenzas: the roles of solar radiation and vitamin D
    Int J Infect Dis, 14 (12), e1099-105
    DOI 10.1016/j.ijid.2010.09.002, PubMed 21036090
  66. Kwitniewski M, Moan J, Juzeniene A (2010)
    Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy
    Photochem Photobiol Sci, 10 (1), 25-8
    DOI 10.1039/c0pp00193g, PubMed 20978658
  67. Moan J, Juzeniene A (2010)
    Solar radiation and human health
    J Photochem Photobiol B, 101 (2), 109-10
    DOI 10.1016/j.jphotobiol.2010.08.004, PubMed 20833325
  68. Grant WB, Juzeniene A, Moan JE (2010)
    Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries
    Scand J Public Health, 39 (1), 70-8
    DOI 10.1177/1403494810382473, PubMed 20817654
  69. Juzenas P, Juzeniene A (2010)
    Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors
    Photodiagnosis Photodyn Ther, 7 (3), 152-7
    DOI 10.1016/j.pdpdt.2010.06.003, PubMed 20728838
  70. Grant WB, Moan JE, Micu E, Porojnicu AC, Juzeniene A (2010)
    Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers
    Fam Cancer, 9 (4), 659-60; discussion 661-2
    DOI 10.1007/s10689-010-9374-1, PubMed 20711817
  71. Mikolajewska P, Donnelly RF, Garland MJ, Morrow DI, Singh TR, Iani V, Moan J, Juzeniene A (2010)
    Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema
    Pharm Res, 27 (10), 2213-20
    DOI 10.1007/s11095-010-0227-2, PubMed 20676735
  72. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches
    J Pharm Pharmacol, 62 (6), 685-95
    DOI 10.1211/jpp.62.06.0004, PubMed 20636855
  73. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Novel patch-based systems for the localised delivery of ALA-esters
    J Photochem Photobiol B, 101 (1), 59-69
    DOI 10.1016/j.jphotobiol.2010.06.012, PubMed 20634088
  74. Grant WB, Juzeniene A, Lagunova Z, Porojnicu AC, Moan JE (2011)
    Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer
    Int J Cancer, 128 (9), 2249-50
    DOI 10.1002/ijc.25552, PubMed 20626044
  75. Juzeniene A, Juzenas P, Moan J (2010)
    Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo
    Methods Mol Biol, 635, 97-106
    DOI 10.1007/978-1-60761-697-9_7, PubMed 20552342
  76. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
    Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
    J Photochem Photobiol B, 101 (2), 174-8
    DOI 10.1016/j.jphotobiol.2010.04.002, PubMed 20430639
  77. Moan J, Porojnicu AC, Dahlback A, Grant WB, Juzeniene A (2010)
    Where the sun does not shine: is sunshine protective against melanoma of the vulva?
    J Photochem Photobiol B, 101 (2), 179-83
    DOI 10.1016/j.jphotobiol.2010.03.003, PubMed 20359907
  78. Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
    Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses
    J Pharm Sci, 99 (8), 3486-98
    DOI 10.1002/jps.22116, PubMed 20222026
  79. Juzeniene A, Stokke KT, Thune P, Moan J (2010)
    Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure
    J Photochem Photobiol B, 101 (2), 111-6
    DOI 10.1016/j.jphotobiol.2010.01.013, PubMed 20207157
  80. Cicarma E, Mørk C, Porojnicu AC, Juzeniene A, Tam TT, Dahlback A, Moan J (2010)
    Influence of narrowband UVB phototherapy on vitamin D and folate status
    Exp Dermatol, 19 (8), e67-72
    DOI 10.1111/j.1600-0625.2009.00987.x, PubMed 19849714
  81. Mikolajewska P, Iani V, Juzeniene A, Moan J (2009)
    Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema
    Br J Dermatol, 161 (5), 1173-9
    DOI 10.1111/j.1365-2133.2009.09437.x, PubMed 19785604
  82. Cicarma E, Porojnicu AC, Lagunova Z, Dahlback A, Juzeniene A, Moan J (2009)
    Sun and sun beds: inducers of vitamin D and skin cancer
    Anticancer Res, 29 (9), 3495-500
    PubMed 19667143
  83. Juzeniene A, Thu Tam TT, Iani V, Moan J (2009)
    5-Methyltetrahydrofolate can be photodegraded by endogenous photosensitizers
    Free Radic Biol Med, 47 (8), 1199-204
    DOI 10.1016/j.freeradbiomed.2009.07.030, PubMed 19647791
  84. Kwitniewski M, Jankowski D, Jaskiewicz K, Dziadziuszko H, Juzeniene A, Moan J, Ma LW, Peksa R, Kunikowska D, Graczyk A, Kwasny M, Kaliszewski M, Glosnicka R (2009)
    Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin
    Int J Cancer, 125 (7), 1721-7
    DOI 10.1002/ijc.24488, PubMed 19521986
  85. Juzeniene A, Setlow R, Porojnicu A, Steindal AH, Moan J (2009)
    Development of different human skin colors: a review highlighting photobiological and photobiophysical aspects
    J Photochem Photobiol B, 96 (2), 93-100
    DOI 10.1016/j.jphotobiol.2009.04.009, PubMed 19481954
  86. Pudroma X, Moan J, Ma LW, Iani V, Juzeniene A (2009)
    A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin
    Exp Dermatol, 18 (11), 985-7
    DOI 10.1111/j.1600-0625.2009.00863.x, PubMed 19469901
  87. Cicarma E, Tuorkey M, Juzeniene A, Ma LW, Moan J (2009)
    Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells
    Br J Dermatol, 161 (2), 413-8
    DOI 10.1111/j.1365-2133.2009.09180.x, PubMed 19438460
  88. Juzeniene A, Nielsen KP, Zhao L, Ryzhikov GA, Biryulina MS, Stamnes JJ, Stamnes K, Moan J (2008)
    Changes in human skin after topical PDT with hexyl aminolevulinate
    Photodiagnosis Photodyn Ther, 5 (3), 176-81
    DOI 10.1016/j.pdpdt.2008.07.001, PubMed 19356652
  89. Donnelly RF, McCarron PA, Al-Kassas R, Juzeniene A, Juzenas P, Iani V, Woolfson AD, Moan J (2009)
    Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles
    Biopharm Drug Dispos, 30 (2), 55-70
    DOI 10.1002/bdd.645, PubMed 19226650
  90. Wold JP, Veberg Dahl A, Lundby F, Nilsen AN, Juzeniene A, Moan J (2008)
    Effect of oxygen concentration on photo-oxidation and photosensitizer bleaching in butter
    Photochem Photobiol, 85 (3), 669-76
    DOI 10.1111/j.1751-1097.2008.00492.x, PubMed 19140897
  91. Juzenas P, Juzeniene A, Iani V, Moan J (2008)
    Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model
    Photochem Photobiol, 85 (3), 760-4
    DOI 10.1111/j.1751-1097.2008.00496.x, PubMed 19140894
  92. Donnelly RF, Morrow DI, McCarron PA, David Woolfson A, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
    Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer
    Photochem Photobiol, 85 (1), 195-204
    DOI 10.1111/j.1751-1097.2008.00417.x, PubMed 18764907
  93. Steindal AH, Tam TT, Lu XY, Juzeniene A, Moan J (2008)
    5-Methyltetrahydrofolate is photosensitive in the presence of riboflavin
    Photochem Photobiol Sci, 7 (7), 814-8
    DOI 10.1039/b718907a, PubMed 18597029
  94. Donnelly RF, Morrow DI, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
    Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy
    J Control Release, 129 (3), 154-62
    DOI 10.1016/j.jconrel.2008.05.002, PubMed 18556084
  95. Juzeniene A, Juzenas P, Iani V, Moan J (2007)
    Topical applications of iron chelators in photosensitization
    Photochem Photobiol Sci, 6 (12), 1268-74
    DOI 10.1039/b703861e, PubMed 18046481
  96. Juzeniene A, Peng Q, Moan J (2007)
    Milestones in the development of photodynamic therapy and fluorescence diagnosis
    Photochem Photobiol Sci, 6 (12), 1234-45
    DOI 10.1039/b705461k, PubMed 18046478
  97. Gonzalez H, Tarras-Wahlberg N, Strömdahl B, Juzeniene A, Moan J, Larkö O, Rosén A, Wennberg AM (2007)
    Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps
    BMC Dermatol, 7, 1
    DOI 10.1186/1471-5945-7-1, PubMed 17324264
  98. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2006)
    Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin
    Br J Dermatol, 155 (4), 791-9
    DOI 10.1111/j.1365-2133.2006.07484.x, PubMed 16965430
  99. Juzeniene A, Juzenas P, Bronshtein I, Vorobey A, Moan J (2006)
    The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid
    J Photochem Photobiol B, 84 (2), 161-6
    DOI 10.1016/j.jphotobiol.2006.02.009, PubMed 16624569
  100. Juzeniene A, Nielsen KP, Moan J (2006)
    Biophysical aspects of photodynamic therapy
    J Environ Pathol Toxicol Oncol, 25 (1-2), 7-28
    DOI 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.20, PubMed 16566708
  101. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2004)
    Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
    Lasers Med Sci, 19 (3), 139-49
    DOI 10.1007/s10103-004-0314-x, PubMed 15503248
  102. Juzeniene A, Ma LW, Juzenas P, Iani V, Lange N, Moan J (2002)
    Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo
    Cell Mol Biol (Noisy-le-grand), 48 (8), 911-6
    PubMed 12699250
  103. Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J (2002)
    Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin
    Photochem Photobiol, 76 (4), 452-6
    DOI 10.1562/0031-8655(2002)076<0452:teoaop>2.0.co;2, PubMed 12405155
  104. Juzeniene A, Juzenas P, Iani V, Moan J (2002)
    Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model
    Photochem Photobiol, 76 (3), 329-34
    DOI 10.1562/0031-8655(2002)076<0329:taoaaa>2.0.co;2, PubMed 12403455
  105. Juzeniene A, Brekke P, Dahlback A, Andersson-Engels S, Reichrath J, Moan K, Holick MF, Grant WB, Moan J (2011)
    Solar radiation and human health
    Rep. Prog. Phys., 74 (6), 066701
    DOI 10.1088/0034-4885/74/6/066701
  106. Juzenas P, Generalov R, Juzeniene A, Moan J (2008)
    Generation of Nitrogen Oxide and Oxygen Radicals by Quantum Dots
    J. Biomed. Nanotechnol., 4 (4), 450-456
    DOI 10.1166/jbn.2008.008
  107. Juzeniene A, Kaliszewski M, Bugaj A, Moan J (2009)
    Clearance of protoporphyrin IX induced by 5-aminolevulinic acid from WiDr human colon carcinoma cells
    PROC SPIE, 7380, 73802Q
    DOI 10.1117/12.822944
  108. Juzeniene A (2009)
    Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis
    Photodiagnosis Photodyn. Ther., 6 (2), 94-96
    DOI 10.1016/j.pdpdt.2009.06.001
  109. Mikolajewska P, Juzeniene A, Iani V, Sollund H, Norsang G, Moan J (2009)
    A pilot study comparing the pain sensations during PpIX build-up and clearance phases
    PROC SPIE, 7380, 73802Y
    DOI 10.1117/12.822949
  110. Generalov R, Lukoseviciute S, Juzeniene A, Juzenas P (2010)
    Cytotoxicity and Phototoxicity of Red Fluorescent Nontargeted Quantum Dots
    IEEE J. Sel. Top. Quantum Electron., 16 (4), 997-1003
    DOI 10.1109/JSTQE.2009.2034387
  111. Peng Q, Juzeniene A, Chen J, Svaasand LO, Warloe T, Giercksky KE, Moan J (2008)
    Lasers in medicine
    Rep. Prog. Phys., 71 (5), 056701
    DOI 10.1088/0034-4885/71/5/056701

 
Page visits: 3193
Scroll to top